Novelix Pharmaceuticals Achieves 52-Week High Amid Strong Market Activity and Investor Interest
Novelix Pharmaceuticals has achieved a new 52-week high of Rs. 44.28, reflecting strong investor interest and significant performance in the retailing sector. The stock has outperformed its sector and has shown notable gains over recent days, contributing to an impressive annual return compared to broader market indices.
Novelix Pharmaceuticals has made headlines today as its stock price reached a new 52-week high of Rs. 44.28, marking a significant milestone for the microcap company in the retailing industry. The stock has shown impressive performance, outperforming its sector by 5.02% and achieving a remarkable 11.56% return over the last three days. Today, Novelix Pharmaceuticals opened with a notable gain of 4.98%, reflecting strong market activity. The stock's intraday high of Rs. 44.28 indicates robust investor interest, as it continues to trade above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a positive trend in its price movement.
In the broader market context, the Sensex is currently trading at 83,508.93, showing a slight increase of 0.08% after a flat opening. The index remains close to its 52-week high, with small-cap stocks leading the market, as evidenced by the BSE Small Cap index gaining 0.52%. Over the past year, Novelix Pharmaceuticals has delivered an impressive 122.74% return, significantly outpacing the Sensex's performance of 4.43%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
